3/26
07:17 am
ptgx
Protagonist Therapeutics Provides Update on VERIFY Patient Enrollment and Timing of Top-line Data [Yahoo! Finance]
Medium
Report
Protagonist Therapeutics Provides Update on VERIFY Patient Enrollment and Timing of Top-line Data [Yahoo! Finance]
3/26
07:00 am
ptgx
Protagonist Therapeutics Provides Update on VERIFY Patient Enrollment and Timing of Top-line Data
Medium
Report
Protagonist Therapeutics Provides Update on VERIFY Patient Enrollment and Timing of Top-line Data
3/18
07:09 am
ptgx
Protagonist Therapeutics Announces Closing of Worldwide Rusfertide License and Collaboration Agreement with Takeda [Yahoo! Finance]
Low
Report
Protagonist Therapeutics Announces Closing of Worldwide Rusfertide License and Collaboration Agreement with Takeda [Yahoo! Finance]
3/18
07:00 am
ptgx
Protagonist Therapeutics Announces Closing of Worldwide Rusfertide License and Collaboration Agreement with Takeda
Medium
Report
Protagonist Therapeutics Announces Closing of Worldwide Rusfertide License and Collaboration Agreement with Takeda
3/15
08:08 am
ptgx
4 Stocks to Buy for Attractive Earnings Acceleration [Yahoo! Finance]
Medium
Report
4 Stocks to Buy for Attractive Earnings Acceleration [Yahoo! Finance]
3/11
07:35 am
ptgx
Late-Breaking Presentation at American Academy of Dermatology 2024 Annual Meeting Shows that JNJ-2113, the First and Only Investigational Targeted Oral Peptide, Maintained Skin Clearance in Moderate-To-Severe Plaque Psoriasis Through One Year [Yahoo! Fina
Low
Report
Late-Breaking Presentation at American Academy of Dermatology 2024 Annual Meeting Shows that JNJ-2113, the First and Only Investigational Targeted Oral Peptide, Maintained Skin Clearance in Moderate-To-Severe Plaque Psoriasis Through One Year [Yahoo! Fina
3/11
07:00 am
ptgx
Late-Breaking Presentation at American Academy of Dermatology 2024 Annual Meeting Shows that JNJ-2113, the First and Only Investigational Targeted Oral Peptide, Maintained Skin Clearance in Moderate-To-Severe Plaque Psoriasis Through One Year
Medium
Report
Late-Breaking Presentation at American Academy of Dermatology 2024 Annual Meeting Shows that JNJ-2113, the First and Only Investigational Targeted Oral Peptide, Maintained Skin Clearance in Moderate-To-Severe Plaque Psoriasis Through One Year
3/9
01:37 pm
ptgx
Johnson & Johnson highlights psoriasis candidate with long-term data [Seeking Alpha]
Medium
Report
Johnson & Johnson highlights psoriasis candidate with long-term data [Seeking Alpha]
3/6
04:10 pm
ptgx
Protagonist Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Protagonist Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
3/6
04:05 pm
ptgx
Protagonist Therapeutics to Participate in Upcoming Investor Conferences
Low
Report
Protagonist Therapeutics to Participate in Upcoming Investor Conferences
3/3
08:04 am
ptgx
This Just In: Analysts Are Boosting Their Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Outlook for This Year [Yahoo! Finance]
Low
Report
This Just In: Analysts Are Boosting Their Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Outlook for This Year [Yahoo! Finance]
3/2
07:54 am
ptgx
Earnings Update: Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Just Reported And Analysts Are Boosting Their Estimates [Yahoo! Finance]
Low
Report
Earnings Update: Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Just Reported And Analysts Are Boosting Their Estimates [Yahoo! Finance]
3/1
02:02 pm
ptgx
Are You Looking for a Top Momentum Pick? Why Protagonist Therapeutics (PTGX) is a Great Choice [Yahoo! Finance]
Low
Report
Are You Looking for a Top Momentum Pick? Why Protagonist Therapeutics (PTGX) is a Great Choice [Yahoo! Finance]
3/1
02:02 pm
ptgx
Earnings Estimates Moving Higher for Protagonist Therapeutics (PTGX): Time to Buy? [Yahoo! Finance]
Low
Report
Earnings Estimates Moving Higher for Protagonist Therapeutics (PTGX): Time to Buy? [Yahoo! Finance]
3/1
02:02 pm
ptgx
Protagonist Therapeutics (PTGX) Upgraded to Buy: What Does It Mean for the Stock? [Yahoo! Finance]
Low
Report
Protagonist Therapeutics (PTGX) Upgraded to Buy: What Does It Mean for the Stock? [Yahoo! Finance]
3/1
12:03 pm
ptgx
Wall Street Analysts Believe Protagonist Therapeutics (PTGX) Could Rally 37.16%: Here's is How to Trade [Yahoo! Finance]
Low
Report
Wall Street Analysts Believe Protagonist Therapeutics (PTGX) Could Rally 37.16%: Here's is How to Trade [Yahoo! Finance]
3/1
11:10 am
ptgx
Recent Price Trend in Protagonist Therapeutics (PTGX) is Your Friend, Here's Why [Yahoo! Finance]
Low
Report
Recent Price Trend in Protagonist Therapeutics (PTGX) is Your Friend, Here's Why [Yahoo! Finance]
2/29
05:27 am
ptgx
We're Not Worried About Protagonist Therapeutics' (NASDAQ:PTGX) Cash Burn [Yahoo! Finance]
Low
Report
We're Not Worried About Protagonist Therapeutics' (NASDAQ:PTGX) Cash Burn [Yahoo! Finance]
2/28
11:06 pm
ptgx
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
2/28
10:16 am
ptgx
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target raised by analysts at JPMorgan Chase & Co. from $34.00 to $37.00. They now have an "overweight" rating on the stock.
Low
Report
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target raised by analysts at JPMorgan Chase & Co. from $34.00 to $37.00. They now have an "overweight" rating on the stock.
2/28
09:20 am
ptgx
Alucio™ Unveils New Meeting Features in Beacon to Elevate HCP Engagement [Yahoo! Finance]
Neutral
Report
Alucio™ Unveils New Meeting Features in Beacon to Elevate HCP Engagement [Yahoo! Finance]
2/28
08:17 am
ptgx
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Low
Report
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
2/27
04:23 pm
ptgx
Protagonist Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
Protagonist Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
2/27
04:05 pm
ptgx
Protagonist Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Low
Report
Protagonist Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
2/25
11:42 am
ptgx
Protagonist Therapeutics: Why I Remain On Sidelines Despite Obvious Promise [Seeking Alpha]
Medium
Report
Protagonist Therapeutics: Why I Remain On Sidelines Despite Obvious Promise [Seeking Alpha]